InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,153.43
(
0.45%
)
Post# of 400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

keitern

Send PM Follow Ignore
Followers 1
Posts 407
Boards Moderated 0
Alias Born 07/20/2006

keitern

Re: surf1944 post# 136

Friday, 11/09/2007 3:00:14 PM

Friday, November 09, 2007 3:00:14 PM

Post# of 400
I don't see how you can fault yourself, buying here. It's not like this company has many liabilities. The purchaser of the genomics division is assuming many liabilities like severance, lease, and other. Plus, GLGC has decided that repositioning is the best use of their database after all, so their money losing strategy is gone, liabilities are assumed by others, and their cash burn is small. I see it as market forces at work and .81 is a resulting absurdity. Just my opinion with shares at .913
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up